Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marek Malecki

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Clinical and Translational Medicine|August 20, 2016
Novel paradigm for immunotherapy of breast cancer by engaging prophylactic immunity against hepatitis BMarek Malecki, Chelsea Sabo, Afsoon Foorohar, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2002
Molecular immunolabeling with recombinant single-chain variable fragment (scFv) antibodies designed with metal-binding domainsMarek Malecki, Annie Hsu, Lynn Truong, et al.
Journal of Stem Cell Research & Therapy|June 18, 2013
TRA-1-60<sup>+</sup>, SSEA-4<sup>+</sup>, POU5F1<sup>+</sup>, SOX2<sup>+</sup>, NANOG<sup>+</sup> Clones of Pluripotent Stem Cells in the Embryonal Carcinomas of the TestesMarek Malecki, Xenia Tombokan, Mark Anderson, et al.
Clinical and Translational Medicine|December 2, 2016
Novel paradigm for immunotherapy of ovarian cancer by engaging prophylactic immunity against hepatitis B virusMarek Malecki, Emily Putzer, Caroline Quach, et al.
Journal of Genetic Syndromes & Gene Therapy|March 4, 2014
Eradication of Human Ovarian Cancer Cells by Transgenic Expression of Recombinant <i>DNASE1, DNASE1L3, DNASE2,</i> and <i>DFFB</i> Controlled by <i>EGFR</i> Promoter: Novel Strategy for Targeted Therapy of CancerMarek Malecki, Jessica Dahlke, Melissa Haig, et al.
Journal of Stem Cell Research & Therapy|July 22, 2014
Safeguarding Stem Cell-Based Regenerative Therapy against Iatrogenic Cancerogenesis: Transgenic Expression of <i>DNASE1</i>, <i>DNASE1L3</i>, <i>DNASE2</i>, <i>DFFB</i> Controlled By <i>POLA1</i> Promoter in Proliferating and Directed Differentiation Resisting Human Autologous Pluripotent Induced Stem Cells Leads to their DeathMarek Malecki, Christine LaVanne, Dominique Alhambra, et al.
Journal of Stem Cell Research & Therapy|January 8, 2013
TRA-1-60<sup>+</sup>, SSEA-4<sup>+</sup>, Oct4A<sup>+</sup>, Nanog<sup>+</sup> Clones of Pluripotent Stem Cells in the Embryonal Carcinomas of the OvariesMarek Malecki, Mark Anderson, Michael Beauchaine, et al.
Molecular and Cellular Therapies|July 22, 2014
Recruitment and retention of human autologous CD34+ CD117+ CD133+ bone marrow stem cells to infarcted myocardium followed by directed vasculogenesis: Novel strategy for cardiac regenerationMarek Malecki, Chelsea Sabo, Emily Putzer, et al.
Journal of Cancer Research & Therapy|May 27, 2014
Stem cells' guided gene therapy of cancer: New frontier in personalized and targeted therapyMaria Mavroudi, Paul Zarogoulidis, Konstantinos Porpodis, et al.
Journal of Genetic Syndromes & Gene Therapy|December 3, 2013
Suicide Gene Therapy for Cancer - Current StrategiesPaul Zarogoulidis, Kaid Darwiche, Antonios Sakkas, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Clinical and Translational Medicine|August 20, 2016
Novel paradigm for immunotherapy of breast cancer by engaging prophylactic immunity against hepatitis BMarek Malecki, Chelsea Sabo, Afsoon Foorohar, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2002
Molecular immunolabeling with recombinant single-chain variable fragment (scFv) antibodies designed with metal-binding domainsMarek Malecki, Annie Hsu, Lynn Truong, et al.
Journal of Stem Cell Research & Therapy|June 18, 2013
TRA-1-60<sup>+</sup>, SSEA-4<sup>+</sup>, POU5F1<sup>+</sup>, SOX2<sup>+</sup>, NANOG<sup>+</sup> Clones of Pluripotent Stem Cells in the Embryonal Carcinomas of the TestesMarek Malecki, Xenia Tombokan, Mark Anderson, et al.
Clinical and Translational Medicine|December 2, 2016
Novel paradigm for immunotherapy of ovarian cancer by engaging prophylactic immunity against hepatitis B virusMarek Malecki, Emily Putzer, Caroline Quach, et al.
Journal of Genetic Syndromes & Gene Therapy|March 4, 2014
Eradication of Human Ovarian Cancer Cells by Transgenic Expression of Recombinant <i>DNASE1, DNASE1L3, DNASE2,</i> and <i>DFFB</i> Controlled by <i>EGFR</i> Promoter: Novel Strategy for Targeted Therapy of CancerMarek Malecki, Jessica Dahlke, Melissa Haig, et al.
Journal of Stem Cell Research & Therapy|July 22, 2014
Safeguarding Stem Cell-Based Regenerative Therapy against Iatrogenic Cancerogenesis: Transgenic Expression of <i>DNASE1</i>, <i>DNASE1L3</i>, <i>DNASE2</i>, <i>DFFB</i> Controlled By <i>POLA1</i> Promoter in Proliferating and Directed Differentiation Resisting Human Autologous Pluripotent Induced Stem Cells Leads to their DeathMarek Malecki, Christine LaVanne, Dominique Alhambra, et al.
Journal of Stem Cell Research & Therapy|January 8, 2013
TRA-1-60<sup>+</sup>, SSEA-4<sup>+</sup>, Oct4A<sup>+</sup>, Nanog<sup>+</sup> Clones of Pluripotent Stem Cells in the Embryonal Carcinomas of the OvariesMarek Malecki, Mark Anderson, Michael Beauchaine, et al.
Molecular and Cellular Therapies|July 22, 2014
Recruitment and retention of human autologous CD34+ CD117+ CD133+ bone marrow stem cells to infarcted myocardium followed by directed vasculogenesis: Novel strategy for cardiac regenerationMarek Malecki, Chelsea Sabo, Emily Putzer, et al.
Journal of Cancer Research & Therapy|May 27, 2014
Stem cells' guided gene therapy of cancer: New frontier in personalized and targeted therapyMaria Mavroudi, Paul Zarogoulidis, Konstantinos Porpodis, et al.
Journal of Genetic Syndromes & Gene Therapy|December 3, 2013
Suicide Gene Therapy for Cancer - Current StrategiesPaul Zarogoulidis, Kaid Darwiche, Antonios Sakkas, et al.
Pageof 3